Contract Research Organization 株式会社メディサイエンスプラニング

M3 Group


I am Edward C. Ian, joined MPI as a Serior Director of clinical development with over 20 years experiences in clinical research in the US and Asia since 1994. I have developed, executed, and managed Phase II-IV clinical research strategy for Asia Pac, overseeing clinical delivery and developing the infrastructure to support advanced clinical trials and deliver client expectations in a timely, professional, quality focused and cost effective manner.

Vision For MPI

For MPI to be recognized as the Top CRO in Japan, through our dedications and continuous investment in the people, process, and resources to satisfy our sponsors and their project needs.

My business imperatives of MPI/ Goals

  • To recruit and retain qualified and competent staff to meet study needs and ensure project deliverables and key performance targets are achieved at all times
  • To ensure effective and seamless clinical operations and project management processes for data collection and submissions
  • To build up and maintain superior clinical development (phase I to IV) and project delivery capabilities
  • To work and partner with global clients and Investigators with respect and enthusiasm
  • To be a committed team leader and a significant contributor in a highly-involved Executive Management team



  • 優秀な人材を採用・維持し、常にプロジェクトの成果と業績目標を担保・達成すること
  • 臨床開発における効率的でシームレスな枠組みと、データ収集や提出のためのプロジェクトマネジメントプロセスを持続すること
  • 臨床開発第 1 ~ 4 相試験及びプロジェクト成果物を上質な形で創出する能力を確立・持続すること
  • 尊敬と熱意を抱いて、グローバルクライアントや治験医師と共に協働すること
  • 上級マネジメントチームの一員として、熱意を持ったチームリーダーかつ多大な影響を与える貢献者たること